Addressing Hypertension Care in Africa Program
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorJohns Hopkins University
About this trial
The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.
Eligibility criteria
Qualifiers
Aged 18 -70 years.
Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis.
Hypertension treatment naive or on monotherapy.
Receives primary care at one of the participating sites.
Disqualifiers
Age <18 years or >70 years.
Severely elevated BP (≥180/110mmHg).
Diagnosis of stroke, coronary artery disease, or kidney disease.
Diagnosis of end-stage renal disease (ESRD) treated with dialysis.
Trial design
Treatments tested in this trial
- ADHINCRA Program
Treatment groups
800 Participants
are divided into 4 treatment groupsSponsors and collaborators
Johns Hopkins University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov